Rezvilutamide plus docetaxel in chemotherapy-naive metastatic castration-resistant prostate cancer patients after progression on abiraterone: A multi-centre, open-label, phase II trial
在阿比特龙治疗后疾病进展的初治转移性去势抵抗性前列腺癌患者中,瑞维鲁胺联合多西他赛的疗效评估:一项多中心、开放标签的II期临床试验
期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70649
Liu, Zhenhua; Chen, Bo; Dai, Tao; Jiang, Shusuan; Luo, Hong; Liao, Hong; Yu, Dexin; Chen, Zhiwen; Zhang, Dahong; Li, Zeng; Zhang, Zhiqiang; Bai, Hong; Liu, Feng; Lin, Jiaqin; Wang, Yike; Feng, Ping; Wei, Qiang